The Division of Cardiovascular and Thoracic Surgery is internationally recognized as a leader in the field and committed to providing excellent quality care for the most complex cardiovascular and thoracic surgeries, while educating the next generation of leaders and moving the field forward through research. We are one of the top centers for heart and lung surgery in the world, a reflection of not only the superior expertise of our surgeons but also the quality of comprehensive, personalized care we give to all our patients.
Our team of surgeons continue to be world leaders in the field of the surgical treatment of chronic pulmonary emboli via pulmonary thromboendarterectomy (PTE), with the largest number of patients and best outcomes.
Our faculty also perform minimally invasive and robotic cardiac and thoracic surgeries; complex adult-congenital corrections; complex neonatal surgeries; the full spectrum of endovascular procedures, including TAVR's and MitraClip procedures; and complex aortic surgeries. We have a long tradition of providing treatment for end-stage heart and lung disease, including heart and lung transplantation and innovative mechanical assist device procedures. Our heart transplant and ventricular assist programs have grown significantly over the last decade, while maintaining excellent outcomes. We are now one of the national leaders in biventricular assist device procedures, which we recognize as a superior option to the Total Artificial Heart.